Cambridge Cognition Holdings Changes its Auditor to Crowe UK LLP

Cambridge Cognition
[shareaholic app="share_buttons" id_name="post_below_content"]

Cambridge Cognition Holdings plc (LON:COG), which develops and markets digital solutions to assess brain health, has announced that the Board has approved the appointment of Crowe UK LLP as the Group’s new external auditor following a competitive audit tender process, and that Grant Thornton UK LLP has resigned as the Group’s auditor.

Crowe will conduct the audit of the Group’s financial statements for the financial period to 31 December 2023 and a proposal to re-appoint Crowe as auditors of the Group will be subject to the approval of shareholders at the 2024 Annual General Meeting.

Grant Thornton has been the auditor for the Company since 2013 and we thank them for their services over this time.  Grant Thornton has confirmed to the Company that there are no matters connected with their ceasing to hold office that need to be brought to the attention of the members or creditors of the Company for the purposes of section 519 of the Companies Act 2006.

Cambridge Cognition is a technology company developing digital health products to better understand, detect and treat conditions affecting brain health. The Company’s software products assess cognitive health in patients worldwide to improve clinical trial outcomes, identify and stratify patients early and improve global efficiency in pharmaceutical and healthcare industries.

We’ll keep you in the loop!

Join 1,000's of investors who read our articles first

We don’t spam! Read our privacy policy for more info.

Twitter
LinkedIn
Facebook
Email
Reddit
Telegram
WhatsApp
Pocket
Find more news, interviews, share price & company profile here for:
Cambridge Cognition Holdings plc announces the formation of a Scientific Advisory Board to guide brain health strategies and market trends effectively.
Cambridge Cognition Holdings plc partners with ActiGraph to enhance brain health assessments in clinical trials, aiming to improve treatments for CNS disorders.
Cambridge Cognition Holdings plc has announced the appointment of Stuart Gall and Philip Rodgers as independent non-executive Directors, to support the company's growth plans in the healthcare and technology sectors.

Search

Search